LABORATORY RESEARCH Epidithiodiketopiperazines (ETPs) Exhibit In Vitro Antiangiogenic and In Vivo Antitumor Activity by Disrupting the HIF-1alpha/p300 Complex in a Preclinical Model of Prostate Cancer Several members of the ETP family of natural products have been shown to disrupt the hypoxia inducible factor-1 alpha (HIF-1alpha)/p300 complex in vitro; namely, gliotoxin, chaetocin, and chetomin. Here, scientists further characterized the molecular mechanisms underlying the antiangiogenic and antitumor effects of these ETPs using a preclinical model of prostate cancer. [Mol Cancer] Abstract | Full Article Cholesterol-Induced Activation of TRPM7 Regulates Cell Proliferation, Migration, and Viability of Human Prostate Cells Researchers demonstrated that cholesterol increases Ca2+ entry via the TRPM7 channel, which promoted proliferation of prostate cells by inducing the activation of the AKT and/or the ERK pathway. [Biochim Biophys Acta] Full Article Cross-Communication between Histone H3 and H4 Acetylation and Akt-mTOR Signaling in Prostate Cancer Cells Scientists evaluated whether cross-communication exists between mammalian target of rapamycin (mTOR) signaling and epigenetic events regulated by histone deacetylase. [J Cell Mol Med] Full Article Tumor-Suppressive MicroRNA-224 Inhibits Cancer Cell Migration and Invasion via Targeting Oncogenic TPD52 in Prostate Cancer Scientists found that restoration of microRNA-224 (miR-224) significantly inhibits prostate cancer cell migration and invasion. Additionally, they found that oncogenic TPD52 is a direct target of miR-224 regulation. [FEBS Lett] Abstract Androgen Receptor Downregulation and Cellular Apoptosis by PMA in Prostate Cancer Cells Researchers investigated the mechanistic action of phorbol 12-myristate 13-acetate (PMA) in prostate cancer cells with regard to androgen receptor (AR). They showed that PMA decreased E2F-1 as well as AR expression in androgen-dependent prostate cancer LNCaP cells. [J Mol Endocrinol] Abstract Corticotropin-Releasing Hormone Receptors Mediate Apoptosis via Cytosolic Calcium-Dependent Phospholipase A2 and Migration in Prostate Cancer Cell RM-1 Researchers investigated cytosolic calcium-dependent phospholipase A2 bridging corticotropin-releasing hormone receptor (CRHR) activations and Bcl-2:Bax ratio and the effect of CRHR activation on cell migration. [J Mol Endocrinol] Abstract Hypermethylation-Mediated Transcriptional Repression of TMPRSS2 in Androgen Receptor-Negative Prostate Cancer Cells Researchers demonstrated that androgen receptor-negative prostate cancer cells showed low expression levels and hypermethylation of TMPRSS2. [Exp Biol Med] Full Article CLINICAL RESEARCH Targeting DNA Repair with Combination Veliparib (ABT-888) and Temozolomide in Patients with Metastatic Castration-Resistant Prostate Cancer Scientists assessed the efficacy and safety of low dose oral poly (ADP-ribose) polymerase inhibitor veliparib and temozolomide in docetaxel-pretreated patients with metastatic castration-resistant prostate cancer in a single-arm, open-label, pilot study. [Invest New Drugs] Abstract Safety, Tolerability and Anti-Tumor Activity of the Androgen Biosynthesis Inhibitor ASP9521 in Patients with Metastatic Castration-Resistant Prostate Cancer: Multi-Center Phase I/II Study In patients with metastatic castration-resistant prostate cancer, ASP9521 demonstrated dose-proportional increase in exposure over the doses evaluated, with an acceptable safety and tolerability profile. However, the novel androgen biosynthesis inhibitor showed no relevant evidence of clinical activity. [Invest New Drugs] Abstract The Efficacy and Safety of Docetaxel Plus Thalidomide vs. Docetaxel Alone in Patients with Androgen-Independent Prostate Cancer: A Systematic Review Researchers investigated the efficacy and safety of docetaxel plus thalidomide vs. docetaxel alone for treating androgen-independent prostate cancer. [Sci Rep] Full Article |